MY156362A - 1h-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof - Google Patents
1h-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereofInfo
- Publication number
- MY156362A MY156362A MYPI2011005108A MYPI2011005108A MY156362A MY 156362 A MY156362 A MY 156362A MY PI2011005108 A MYPI2011005108 A MY PI2011005108A MY PI2011005108 A MYPI2011005108 A MY PI2011005108A MY 156362 A MY156362 A MY 156362A
- Authority
- MY
- Malaysia
- Prior art keywords
- group
- pyrazolo
- preparation
- therapeutic use
- isoquinoline derivatives
- Prior art date
Links
- YMYHYKRSWYKSJM-UHFFFAOYSA-N 1h-pyrazolo[4,3-c]isoquinoline Chemical class N1=CC2=CC=CC=C2C2=C1C=NN2 YMYHYKRSWYKSJM-UHFFFAOYSA-N 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- -1 PHENYL GROUP Chemical group 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0901995A FR2944792B1 (fr) | 2009-04-24 | 2009-04-24 | Derives de 1h-pyrazolo[4,3-c]isoquinoleines, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY156362A true MY156362A (en) | 2016-02-15 |
Family
ID=41259738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2011005108A MY156362A (en) | 2009-04-24 | 2010-04-22 | 1h-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8461175B2 (enExample) |
| EP (1) | EP2421864B1 (enExample) |
| JP (1) | JP5722880B2 (enExample) |
| KR (1) | KR101675609B1 (enExample) |
| CN (1) | CN102459260B (enExample) |
| AR (1) | AR076393A1 (enExample) |
| AU (1) | AU2010240742B2 (enExample) |
| BR (1) | BRPI1013724A2 (enExample) |
| CA (1) | CA2791947A1 (enExample) |
| CY (1) | CY1115678T1 (enExample) |
| DK (1) | DK2421864T3 (enExample) |
| ES (1) | ES2515240T3 (enExample) |
| FR (1) | FR2944792B1 (enExample) |
| HR (1) | HRP20141058T1 (enExample) |
| IL (1) | IL215733A (enExample) |
| MX (1) | MX2011011246A (enExample) |
| MY (1) | MY156362A (enExample) |
| PL (1) | PL2421864T3 (enExample) |
| PT (1) | PT2421864E (enExample) |
| RU (1) | RU2530775C2 (enExample) |
| SG (1) | SG175338A1 (enExample) |
| SI (1) | SI2421864T1 (enExample) |
| TW (1) | TWI468405B (enExample) |
| UY (1) | UY32575A (enExample) |
| WO (1) | WO2010122272A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109020972B (zh) * | 2018-10-08 | 2021-03-09 | 广东石油化工学院 | 一种三唑并[1，5-a]喹啉衍生物的制备方法 |
| WO2023039510A1 (en) * | 2021-09-10 | 2023-03-16 | The Trustees Of Columbia University In The City Of New York | Gpx4 inhibitors and uses thereof |
| CN116535356A (zh) * | 2023-03-06 | 2023-08-04 | 中国药科大学 | 3-氨基-5-苯基-吡唑类衍生物微管蛋白抑制剂及其制备和医药用途 |
| EP4506003A1 (en) | 2023-08-07 | 2025-02-12 | S.Yu Yunusov Institute of Chemistry of Plant Substances of the Academy of Sciences of the Republic of Uzbekistan | Halogen derivatives of (4´,5´- methylenedioxyphenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline for use in the treatment of leukemia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8600752D0 (en) * | 1986-01-14 | 1986-02-19 | Roussel Lab Ltd | Chemical compounds |
| DE10229762A1 (de) * | 2002-07-03 | 2004-01-22 | Aventis Pharma Deutschland Gmbh | Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase |
| US7132428B2 (en) * | 2003-07-03 | 2006-11-07 | Aventis Pharmaceuticals Inc. | Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders |
| CA2531291A1 (en) * | 2003-07-03 | 2005-02-10 | Aventis Pharmaceuticals Inc. | Pyrazoloisoquinoline derivatives as kinase inhibitors |
| AU2004259012C1 (en) * | 2003-07-23 | 2012-08-02 | Exelixis, Inc. | Anaplastic lymphoma kinase modulators and methods of use |
| AR058223A1 (es) * | 2005-11-25 | 2008-01-23 | Palau Pharma Sa | Un comuesto de derivados de pirazoloisoquinolina, un procedimiento para l a preparacion de dicho compuesto y una composicion farmaceutica que comprende dicho compuesto |
-
2009
- 2009-04-24 FR FR0901995A patent/FR2944792B1/fr not_active Expired - Fee Related
-
2010
- 2010-04-22 CA CA2791947A patent/CA2791947A1/fr not_active Abandoned
- 2010-04-22 SI SI201030757T patent/SI2421864T1/sl unknown
- 2010-04-22 MY MYPI2011005108A patent/MY156362A/en unknown
- 2010-04-22 ES ES10723723.2T patent/ES2515240T3/es active Active
- 2010-04-22 HR HRP20141058AT patent/HRP20141058T1/hr unknown
- 2010-04-22 US US13/265,981 patent/US8461175B2/en not_active Expired - Fee Related
- 2010-04-22 BR BRPI1013724A patent/BRPI1013724A2/pt not_active IP Right Cessation
- 2010-04-22 SG SG2011077963A patent/SG175338A1/en unknown
- 2010-04-22 EP EP10723723.2A patent/EP2421864B1/fr active Active
- 2010-04-22 CN CN201080028355.1A patent/CN102459260B/zh not_active Expired - Fee Related
- 2010-04-22 MX MX2011011246A patent/MX2011011246A/es active IP Right Grant
- 2010-04-22 PT PT107237232T patent/PT2421864E/pt unknown
- 2010-04-22 PL PL10723723T patent/PL2421864T3/pl unknown
- 2010-04-22 KR KR1020117027900A patent/KR101675609B1/ko not_active Expired - Fee Related
- 2010-04-22 AU AU2010240742A patent/AU2010240742B2/en not_active Ceased
- 2010-04-22 JP JP2012506551A patent/JP5722880B2/ja not_active Expired - Fee Related
- 2010-04-22 DK DK10723723.2T patent/DK2421864T3/da active
- 2010-04-22 RU RU2011147658/04A patent/RU2530775C2/ru not_active IP Right Cessation
- 2010-04-22 WO PCT/FR2010/050773 patent/WO2010122272A1/fr not_active Ceased
- 2010-04-23 UY UY0001032575A patent/UY32575A/es not_active Application Discontinuation
- 2010-04-23 TW TW99112914A patent/TWI468405B/zh not_active IP Right Cessation
- 2010-04-23 AR ARP100101357A patent/AR076393A1/es unknown
-
2011
- 2011-10-11 IL IL215733A patent/IL215733A/en not_active IP Right Cessation
-
2014
- 2014-10-30 CY CY20141100897T patent/CY1115678T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX343274B (es) | Inhibidores de la replicacion del vih. | |
| MX2011007455A (es) | Derivados oxadiazol como agonistas de los receptores de esfingosina-1-fosfato 1 (s1p1). | |
| WO2012103071A3 (en) | Compounds and compositions | |
| TW200626610A (en) | Analogs of 17-hydroxywortmannin as PI3K inhibitors | |
| MX2009004920A (es) | Nuevos derivados de aminopirimidina como inhibidores de plk1. | |
| MY203060A (en) | Prophylactic or therapeutic agent for spinal muscular atrophy | |
| WO2009069736A1 (ja) | 含窒素化合物 | |
| MX2013005734A (es) | Derivados de heteroarilsulfonamidas, su preparacion y su aplicacion en terapia humana. | |
| BR112013021941A2 (pt) | agente terapêutico para tumor | |
| PH12012501643A1 (en) | Pyrazolopyrimidine compounds and their use as pde 10 inhibitors | |
| UA95972C2 (ru) | Аминопиридиновые производные с селективной ингибирующей активностью в отношении авроры а | |
| WO2010130934A3 (fr) | Derives de 2-cycloamino-5-(pyridin-4-yl)imidazo[2,1-b][1,3,4]thiadiazole, leur preparation et leur application en therapeutique | |
| MY156362A (en) | 1h-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof | |
| MX2011013449A (es) | Derivados 774 de 2-carboxamida-7-piperazinil-benzofurano. | |
| WO2009007536A8 (fr) | Dérivés de 7 -alkynyl-1,8-naphthyridones, leur préparation et leur application en thérapeutique | |
| MX2016003422A (es) | Imidazo[1,2-a]piridina-7-aminas como herramientas de imagen. | |
| MX2011012057A (es) | Derivados de ciclopenta [c] pirrolilalquilcarbamatos de heterociclos de 5 miembros, su preparación y su uso en terapéutica. | |
| MY179886A (en) | Aminocyclobutane derivatives, method for preparing same and the use thereof as drugs | |
| MX2012008147A (es) | Derivados de pirrazolopiridina. | |
| TW200626605A (en) | Novel bis-azaindole derivatives, their preparation and their pharmaceutical use as kinase inhibitors | |
| MX2011009746A (es) | Derivados de n-[(6-aza-biciclo[3.2.1]oct-5-il)-abril-metil]-hetero benzamida, su prepracion y su uso en terapeutica. | |
| WO2009106750A3 (fr) | Dérivés 6-heterocyclique-imidazo[1,2-a]pyrroine-2-carboxamides, leur préparation et leur application en thérapeutique | |
| WO2009129259A3 (en) | Polymorphs of 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n-(1-methylpiperidin-4-yl)-9h-pyrido[2,3-b]indole-7-carboxamide and methods of use therefor | |
| TW200708506A (en) | Derivatives of triazines, their preparation and their application in therapeutics | |
| MX2010007350A (es) | Derivados de 2-heteroaroil-imidazol[1,2-a]piridina, su preparacion y aplicacion terapeutica. |